Bone marrow mesenchymal stem cell-derived exosomes protect podocytes from HBx-induced ferroptosis

Xiaoqian Yang1, Yani Yu1, Baoshuang Li1

  • 1Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Peerj
|May 16, 2023
PubMed

Insights

Bone marrow mesenchymal stem cell-derived exosomes (BMSC-exosomes) show potential in treating Hepatitis B virus-associated glomerulonephritis (HBV-GN). These exosomes inhibit ferroptosis in kidney podocytes by transferring miR-223-3p, offering a novel therapeutic strategy for HBV-GN.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Medicine

Background:

  • Hepatitis B virus-associated glomerulonephritis (HBV-GN) is a significant cause of kidney disease in China, with unclear pathogenesis and limited treatment options.
  • Podocyte injury and ferroptosis are implicated in HBV-GN progression.

Purpose of the Study:

  • To investigate the protective mechanism of exosomes derived from bone marrow mesenchymal stem cells (BMSCs) against HBV-induced podocyte injury.
  • To elucidate the role of miR-223-3p in this protective process.

Main Methods:

  • Human renal podocytes were transfected with HBx protein to mimic HBV infection.
  • Cell viability, iron content, malondialdehyde (MDA), and reactive oxygen species (ROS) levels were assessed.
  • Expression of ferroptosis-related molecules was analyzed using qRT-PCR and Western blot.
  • The effect of BMSC-derived exosomes and miR-223-3p was evaluated using inhibitors.

Main Results:

  • HBx overexpression reduced podocyte viability and induced ferroptosis, evidenced by altered expression of GPX4, SLC7A11, and ACSL4, and increased iron, MDA, and ROS levels.
  • BMSC-derived exosomes protected podocytes from HBx-induced ferroptosis.
  • miR-223-3p was enriched in BMSC-derived exosomes, and its inhibition reversed the protective effects.

Conclusions:

  • BMSC-derived exosomes exert a protective effect against HBx-induced podocyte ferroptosis.
  • This inhibition occurs through the transfer of miR-223-3p, highlighting a novel therapeutic pathway for HBV-GN.
Abstract

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K